Skip to main content
Arthritis and rheumatism
Systemic sulfa-induced Sweet's syndrome.
The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis.
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
Introduction to special section: cost and social and psychological impact of rheumatic diseases.
Disability in valued life activities among individuals with systemic lupus erythematosus.
Admixed populations and autoimmunity.
Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
Impact of memory impairment on employment status in persons with systemic lupus erythematosus.
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial.
Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.
